790 related articles for article (PubMed ID: 28125438)
21. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
[TBL] [Abstract][Full Text] [Related]
23. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
[TBL] [Abstract][Full Text] [Related]
24. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
[TBL] [Abstract][Full Text] [Related]
25. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model.
Wang ST; Hua ZX; Fan DX; Zhang X; Ren K
Biomed Res Int; 2019; 2019():3901907. PubMed ID: 31192255
[TBL] [Abstract][Full Text] [Related]
26. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
[TBL] [Abstract][Full Text] [Related]
27. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
[TBL] [Abstract][Full Text] [Related]
28. Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide.
Funke SKI; Factor C; Rasschaert M; Lezius L; Sperling M; Karst U; Robert P
Radiology; 2022 Oct; 305(1):179-189. PubMed ID: 35727155
[TBL] [Abstract][Full Text] [Related]
29. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study.
Fretellier N; Idée JM; Dencausse A; Karroum O; Guerret S; Poveda N; Jestin G; Factor C; Raynal I; Zamia P; Port M; Corot C
Invest Radiol; 2011 May; 46(5):292-300. PubMed ID: 21263333
[TBL] [Abstract][Full Text] [Related]
32. Elemental Bioimaging of Sheep Bone and Articular Cartilage After Single Application of Gadolinium-Based Contrast Agents.
Richter H; Verlemann C; Jeibmann A; Martin LF; Luebke AM; Karol A; Sperling M; Radbruch A; Karst U
Invest Radiol; 2024 Apr; 59(4):287-292. PubMed ID: 37747456
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
[TBL] [Abstract][Full Text] [Related]
35. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
[TBL] [Abstract][Full Text] [Related]
36. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
[TBL] [Abstract][Full Text] [Related]
37. Species-dependent interaction of Gd-based contrast agents with humic substances.
Sommer K; Sperling M; Karst U
Chemosphere; 2022 Aug; 300():134528. PubMed ID: 35427668
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
39. Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.
Fretellier N; Poteau N; Factor C; Mayer JF; Medina C; Port M; Idée JM; Corot C
Invest Radiol; 2014 Dec; 49(12):766-72. PubMed ID: 24943092
[TBL] [Abstract][Full Text] [Related]
40. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]